$NTRP
NextTrip, Inc. Stock $ntrp

$ntrp Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040485 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue		$142.0K	$188.2K
YoY Change		-24.57%	-73.12%
Cost Of Revenue		$176.1K	$79.71K
YoY Change		120.94%	-51.62%
Gross Profit		-$34.13K	$108.5K
YoY Change		-131.45%	-79.73%
Gross Profit Margin		-24.04%	57.65%
Selling, General & Admin		$690.0K	$1.940M
YoY Change		-64.43%	-16.23%
% of Gross Profit			1787.23%
Research & Development		$245.00	$152.2K
YoY Change		-99.84%	15.54%
% of Gross Profit			140.28%
Depreciation & Amortization		$24.55K	$26.86K
YoY Change		-8.58%	-3.01%
% of Gross Profit			24.75%
Operating Expenses		$866.2K	$2.393M
YoY Change		-63.8%	-20.94%
Operating Profit		-$900.3K	-$2.284M
YoY Change		-60.59%	-8.31%
Interest Expense		$3.235K	$1.978K
YoY Change		63.55%	349.55%
% of Operating Profit
Other Income/Expense, Net		$28.67K	-$7.884K
YoY Change		-463.6%
Pretax Income		-$871.7K	-$2.292M
YoY Change		-61.97%	-7.98%
Income Tax
% Of Pretax Income
Net Earnings		-$871.7K	-$2.292M
YoY Change		-61.97%	-7.98%
Net Earnings / Revenue		-613.9%	-1217.73%
Basic Earnings Per Share		-$1.57	-$0.22
Diluted Earnings Per Share		-$1.57	-$218.3K
COMMON SHARES
Basic Shares Outstanding	780.4K shares	10.77M shares	10.50M shares
Diluted Shares Outstanding		560.3K shares	524.9K shares

Balance Sheet

Concept	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$560.0K	$4.801M
YoY Change	-88.33%	-63.25%
Cash & Equivalents	$556.1K	$4.801M
Short-Term Investments
Other Short-Term Assets	$40.00K	$177.7K
YoY Change	-77.49%	36.0%
Inventory	$775.1K	$967.4K
Prepaid Expenses	$37.83K	$177.7K
Receivables	$59.00K	$367.8K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.428M	$6.314M
YoY Change	-77.38%	-57.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$162.0K	$244.8K
YoY Change	-33.85%	21.36%
Goodwill
YoY Change
Intangibles	$1.248M	$1.084M
YoY Change	15.08%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.410M	$1.329M
YoY Change	6.07%	24.21%
TOTAL ASSETS
Total Short-Term Assets	$1.428M	$6.314M
Total Long-Term Assets	$1.410M	$1.329M
Total Assets	$2.838M	$7.643M
YoY Change	-62.87%	-51.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$607.2K	$403.5K
YoY Change	50.47%	80.83%
Accrued Expenses	$145.3K	$287.6K
YoY Change	-49.48%	-33.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$863.6K	$820.9K
YoY Change	5.2%	10.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$863.6K	$820.9K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$863.6K	$820.9K
YoY Change	5.2%	-5.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.41M	-$47.38M
YoY Change	12.71%
Common Stock	$652.00	$10.50K
YoY Change	-93.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.974M	$6.822M
YoY Change
Total Liabilities & Shareholders Equity	$2.838M	$7.643M
YoY Change	-62.87%	-51.59%

Cashflow Statement

Concept	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$871.7K	-$2.292M
YoY Change	-61.97%	-7.98%
Depreciation, Depletion And Amortization	$24.55K	$26.86K
YoY Change	-8.58%	-3.01%
Cash From Operating Activities	-$180.0K	-$2.072M
YoY Change	-91.31%	36.31%
INVESTING ACTIVITIES
Capital Expenditures	$40.00K	-$60.90K
YoY Change	-165.68%	-58.5%
Acquisitions
YoY Change
Other Investing Activities	$40.00K
YoY Change
Cash From Investing Activities	-$10.00K	-$60.90K
YoY Change	-83.58%	-58.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	360.0K	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-180.0K	-2.072M
Cash From Investing Activities	-10.00K	-60.90K
Cash From Financing Activities	360.0K	0.000
Net Change In Cash	170.0K	-2.133M
YoY Change	-107.97%	27.97%
FREE CASH FLOW
Cash From Operating Activities	-$180.0K	-$2.072M
Capital Expenditures	$40.00K	-$60.90K
Free Cash Flow	-$220.0K	-$2.011M
YoY Change	-89.06%	46.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	SASI	State Incentives StateIncentives		usd
CY2022Q3	SASI	State Incentives StateIncentives		usd
	SASI	State Incentives StateIncentives		usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0000788611
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023Q3	SASI	Roundup Value Issued In Connection With Reverse Split RoundupValueIssuedInConnectionWithReverseSplit		usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	SASI	Roundup Value Issued In Connection With Reverse Split RoundupValueIssuedInConnectionWithReverseSplit		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	SASI	Payments For Proceeds From Property And Equipment PaymentsForProceedsFromPropertyAndEquipment		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	SASI	Conversion Of Preferred Shares To Common Shares ConversionOfPreferredSharesToCommonShares		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears		usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable In Three Years OperatingLeasesFutureMinimumPaymentReceivableInThreeYears		usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable In Three Years And There After OperatingLeasesFutureMinimumPaymentReceivableInThreeYearsAndThereAfter		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2023Q3	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedOutstandingAggregateIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38015
	dei	Entity Registrant Name EntityRegistrantName	SIGMA ADDITIVE SOLUTIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1865814
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3900 Paseo del Sol
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Fe
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87507
	dei	City Area Code CityAreaCode	(505)
	dei	Local Phone Number LocalPhoneNumber	438-2576
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	SASI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	780423	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	556087	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2845931	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	371620	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	775066	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950943	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	37833	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	105226	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1427986	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4273720	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161971	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	304903	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1247697	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1125285	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1409668	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1430188	usd
CY2023Q3	us-gaap	Assets Assets	2837654	usd
CY2022Q4	us-gaap	Assets Assets	5703908	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	607212	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	277492	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	111082	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	120073	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	145306	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	231633	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	863600	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	629198	usd
CY2023Q3	us-gaap	Liabilities Liabilities	863600	usd
CY2022Q4	us-gaap	Liabilities Liabilities	629198	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	316	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	316	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	651536	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	651536	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	524940	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	524940	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	652	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	525	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55380026	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54416668	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53406625	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49342484	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1974054	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5074710	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2837654	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5703908	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	141988	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188245	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	369188	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476749	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	176116	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	79713	usd
	us-gaap	Cost Of Revenue CostOfRevenue	276270	usd
	us-gaap	Cost Of Revenue CostOfRevenue	312879	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-34128	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	108532	usd
	us-gaap	Gross Profit GrossProfit	92918	usd
	us-gaap	Gross Profit GrossProfit	163870	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	288894	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1227805	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1774658	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3704633	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	84078	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	275418	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	447417	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	613833	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	245	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	152245	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	232216	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	442548	usd
CY2023Q3	SASI	Investor Public Relations InvestorPublicRelations	15797	usd
CY2022Q3	SASI	Investor Public Relations InvestorPublicRelations	46832	usd
	SASI	Investor Public Relations InvestorPublicRelations	128565	usd
	SASI	Investor Public Relations InvestorPublicRelations	293458	usd
CY2023Q3	SASI	Organizational Costs OrganizationalCosts	47580	usd
CY2022Q3	SASI	Organizational Costs OrganizationalCosts	140522	usd
	SASI	Organizational Costs OrganizationalCosts	137017	usd
	SASI	Organizational Costs OrganizationalCosts	260088	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	251265	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	252886	usd
	us-gaap	Legal Fees LegalFees	587541	usd
	us-gaap	Legal Fees LegalFees	608830	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61077	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	183608	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	309765	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	692640	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24554	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26857	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74151	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88302	usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses	92709	usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses	86783	usd
	us-gaap	Other Expenses OtherExpenses	387582	usd
	us-gaap	Other Expenses OtherExpenses	263747	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	866199	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2392956	usd
	us-gaap	Operating Expenses OperatingExpenses	4078912	usd
	us-gaap	Operating Expenses OperatingExpenses	6968079	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-900327	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2284424	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3985994	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6804209	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	278	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	17	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3025	usd
	SASI	State Incentives StateIncentives	76628	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6184	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3356	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-16950	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	3235	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1978	usd
	us-gaap	Interest Expense InterestExpense	9706	usd
	us-gaap	Interest Expense InterestExpense	5367	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	31905	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	67584	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28666	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7884	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	54539	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	57336	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-871661	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2292308	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3931455	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6746873	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-871661	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2292308	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3931455	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6746873	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	10687	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14220	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	33122	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	42660	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-882348	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2306528	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3964577	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6789533	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.57
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.57
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.39
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.93
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	560310	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	560310	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524940	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524940	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	544587	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	544587	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524940	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524940	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2391289	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-871661	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	453635	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	89080	usd
CY2023Q3	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	5793	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	84078	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1974054	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2292308	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	973	usd
CY2022Q3	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	27152	usd
CY2022Q3	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	275418	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6821768	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5074710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3931455	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	453635	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	89080	usd
	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	19316	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	489	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	447417	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1974054	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6746873	usd
	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	70594	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	24463	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	613833	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6821768	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6821768	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3931455	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6746873	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74151	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88302	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	28632	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-312620	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-44422	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-175877	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	257352	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-67393	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	63446	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	372236	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	197105	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-8991	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-19166	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-86327	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-338297	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2586884	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6386415	usd
	SASI	Payments For Proceeds From Property And Equipment PaymentsForProceedsFromPropertyAndEquipment	83848	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	78000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	145515	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	176104	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67515	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-259952	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	453635	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	89080	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	364555	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2289844	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6646367	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2845931	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11447047	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	556087	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4800680	usd
	us-gaap	Stock Issued1 StockIssued1	33122	usd
	us-gaap	Stock Issued1 StockIssued1	42660	usd
	SASI	Conversion Of Preferred Shares To Common Shares ConversionOfPreferredSharesToCommonShares	188830	usd
	SASI	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	18827	usd
	SASI	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	95057	usd
	us-gaap	Interest Paid Net InterestPaidNet	9706	usd
	us-gaap	Interest Paid Net InterestPaidNet	5367	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20 reverse stock split
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	315839	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	287857	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.57
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.57
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.39
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.93
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-882348	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2306528	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3964577	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6789533	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	560310	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	560310	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524940	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524940	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	544587	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	544587	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524940	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524940	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zys8shRFLfza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z0qF9JRyoUwl">Accounting Estimates</span></b> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2023Q3	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	8503	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	36846	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	115600	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentReceivableRemainderOfFiscalYear	8503	usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable Next Twelve Months OperatingLeasesFutureMinimumPaymentReceivableNextTwelveMonths	8503	usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable OperatingLeasesFutureMinimumPaymentReceivable	17006	usd
CY2023Q3	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	77208	usd
CY2023Q3	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	15203	usd
CY2023Q3	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	62005	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	283401	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	294194	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	108776	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	140723	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	382889	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	516026	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	775066	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950943	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-97818	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-74716	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1247697	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1125285	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23102	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17010	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8033	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	32131	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	32131	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	32131	usd
CY2022Q4	SASI	Finite Lived Intangible Assets Amortization Expense After Year Three FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree	366036	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	470462	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20 reverse stock split
CY2023Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	40197	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	316	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	316	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	447417	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	613833	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0405	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	69795	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	84.80
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	24374	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	50.00
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y5M4D
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	4216	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	87.80
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	89953	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	75.20
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21704	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.60
	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y3M25D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	20930	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	68.59
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	90727	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.58
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M15D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	15876	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	37.11
	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Vested Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedOutstandingWeightedAverageRemainingContractualTerm1	P3Y9M29D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	74851	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	66.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y9M10D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	90727	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.58
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.06
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	278132	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M3D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	199397	shares
CY2021Q4	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	122.00
CY2021	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P2Y1M6D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	8233	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	191164	shares
CY2022Q4	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	93.24
CY2022	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P1Y2M8D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	151483	shares
	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	6.42
	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Grants Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm	P2Y2M8D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	120604	shares
	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled	90.72
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	222043	shares
CY2023Q3	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	26.48
	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P2Y25D
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2391289	usd

Files In Submission

Name	View Source	Status
0001493152-23-040485-index-headers.html	Edgar Link	pending
0001493152-23-040485-index.html	Edgar Link	pending
0001493152-23-040485.txt	Edgar Link	pending
0001493152-23-040485-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sasi-20230930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sasi-20230930_cal.xml	Edgar Link	unprocessable
sasi-20230930_def.xml	Edgar Link	unprocessable
sasi-20230930_pre.xml	Edgar Link	unprocessable
sasi-20230930_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTRP
NextTrip, Inc. Stock $ntrp

2023 Q4 Form 10-Q Financial Statement

#000149315223040485 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP NextTrip, Inc. Stock $ntrp

2023 Q4 Form 10-Q Financial Statement

#000149315223040485 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP
NextTrip, Inc. Stock $ntrp